Treatment of secondary hyperparathyroidism in hemodialyzed patients with high-dose calcium carbonate without vitamin D3 supplements

American Journal of Nephrology

Volumn 19, Issue 3, 1999, Pages 428-432

  Teruel, José L ^a   Tenorio, María T ^a   Rodríguez, José R ^a   Marcén, Roberto ^a   Orofino, Luis ^a   Rivera, Maite ^a   Ortuño, Joaquín ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Calcium carbonate; Hemodialysis; Hyperparathyroidism; Low calcium dialysate

Indexed keywords

CALCIUM; CALCIUM CARBONATE; PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIALYSATE; FEMALE; HEMODIALYSIS; HUMAN; HYPERCALCEMIA; HYPERPHOSPHATEMIA; KIDNEY FAILURE; MALE; ORAL DRUG ADMINISTRATION; PARATHYROID HORMONE BLOOD LEVEL; PATIENT COMPLIANCE; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; TREATMENT FAILURE; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; CALCIUM CARBONATE; CHOLECALCIFEROL; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PARATHYROID HORMONE; RENAL DIALYSIS;

EID: 0033001723     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000013490     Document Type: Article

References (25)

1. Torres A, Lorenzo V, Hernández D, Rodríguez JC, Concepción MT, Rodríguez AP, Hernández A, De Bonis E, Darias E, Gonzáles-Posada JM, Losada M, Rufino M, Felsenfeld AJ, Rodríguez M: Bone disease in predialysis, hemodialysis, and CAPD patients: Evidence of a better bone response to PTH. Kidney Int 1995;47: 1434-1442.
2. Quarles LD, Lobaugh B, Murphy G: Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia. J Clin Endocrinol Metab 1992;75:516-524.
3. Salusky IB, Ramírez JA, Oppenheim W, Gales B, Segre GV, Goodman WG: Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD. Kidney Int 1994;45:253-258.
4. Fournier A, Morinière Ph, Ben Hamida F, El Esjer N, Shenovda M, Ghazali A, Bouzernidi M, Achard JM, Westeel PF: Use of alkaline calcium salts as phosphate binder in uremic patients. Kidney Int 1992;42(suppl 38):S50-S61.
5. Morinière Ph, Boudailliez B, Hocine CH, Cohen ME, Fournier A: Prevention of osteitis fibrosa, aluminum bone disease and soft tissues calcification in dialysis patients: A long term comparison of moderate doses of oral calcium +/-Mg (OH)2 versus A1 (OH)3 +/-1 alpha OH vitamin D3. Nephrol Dial Transplant 1989;4:1045-1053.
6. Sawyer N, Noonan K, Altman P, Marsh F, Cunningham J: High-dose calcium carbonate with stepwise reduction in dialysate calcium concentration: Effective phosphate control and aluminum avoidance in haemodialysis patients. Nephrol Dial Transplant 1989;4:105-109.
7. Berl T, Berns AS, Huffer WE, Hammill K, Alfrey AC, Arnaud CD, Schrier RW: 1,25-Dihydroxycholecalciferol effects in chronic dialysis. Ann Intern Med 1978;88:774-780.
8. Reichel H: Medical management of renal hyperparathyroidism: Pulse treatment with vitamin D metabolites or not? Nephrol Dial Transplant 1994;9:1368-1370.
9. Ritz E, Matthias S, Seidel A, Reichel H, Szabo A, Hörl WH: Disturbed calcium metabolism in renal failure. Pathogenesis and therapeutic strategies. Kidney Int 1992;42(suppl 38):S37-S42.
10. Llach F: Treatment of secondary hyperparathyroidism by intravenous calcitriol. Nefrologia 1993;XIII(suppl 3):39-42.
11. 3, oral CaCO3 and low dialysate calcium. Kidney Int 1993; 43(suppl 41):S121-S124.
12. Quarles LD, Yohay DA, Carroll BA, Spritzer ChE, Minda SA, Bartholomay D, Lobaugh BA: Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD. Kidney Int 1994;45:1710-1721.
13. Goicoechea M, Pérez-García R, Vàzquez MI, Ruiz MA, Vozmediano MC, Valderrábano F: Tratamiento del hiperparatiroidisnio secundario con calcitriol intravenoso. Cuales son los factores relacionados con la falta de respuesta al tratamiento? Nefrología 1996;XVI:531-538.
14. Fischer ER, Harris DCH: Comparison of intermittent oral and intravenous calcitriol in hemodialysis patients with secondary hyperparathyroidism. Clin Nephrol 1993;40:216-220.
15. Herrmann P, Ritz E, Schmidt-Gayk H, Schäfer I, Geyer J, Nonnast-Daniel B, Koch K-M, Weber U, Hörl W, Haas-Wörle A, Kühn K, Bierther B, Schneider P: Comparison of intermittent and continous oral administration of calcitriol in dialysis patients: A randomized prospective trial. Nephron 1994;67:48-53.
16. Dressler R, Laut J, Lynn RI, Ginsberg N: Long-term high dose intravenous calcitriol therapy in end-stage renal disease patients with severe secondary hyperparathyroidism. Clin Nephrol 1995;43:324-331.
17. Fernández E: Estamos utilizando adecuadamente el calcitriol por vía parenteral? Resultados de un cuestionario multicéntrico. Nefrología 1996;XVI:167-173.
18. Van der Merwe WM, Rodger RSC, Grant AC, Logue FC, Cowan RA, Beastall GH, Junor BJR, Briggs JD: Low calcium dialysate and high-dose oral calcitriol in the treatment of secondary hyperparathyroidism in haemodialysis patients. Nephrol Dial Transplant 1990;5:874-877.
19. Muramoto H, Haruki K, Yoshimura A, Mimo N, Oda K, Tofuku Y: Treatment of refractory hyperparathyroidism in patients on hemodialysis by intermittent oral administration of 1,25 (OH)2 vitamin D3. Nephron 1991;58:288-294.
20. Hou SH, Zhao J, Ellman CF, Hu J, Griffin Z, Spiegel DM, Bourdeau JE: Calcium and phosphorus fluxes during hemodialysis with low calcium dialysate. Am J Kidney Dis 1991;18:217-224.
21. Argiles A, Ker PG, Canaud B, Flavier JL, Mion Ch: Calcium kinetics and the long-term effects of lowering dialysate calcium concentration. Kidney Int 1993;43:630-640.
22. Fabrizi F, Bacchini G, DiFilippo S, Pontoriero G, Locatelli F: Intradialytic calcium balances with different calcium dialysate levels. Nephron 1996;72:530-535.
23. Fernández E, Borrás M, Pais B, Montoliu J: Low-calcium dialysate stimulates parathormone secretion and its long-term use worsens secondary hyperparathyroidism. J Am Soc Nephrol 1995;6:132-135.
24. Malberti F, Surian M, Minetti L: Dialysate calcium concentration decrease exacerbates secondary hyperparathyroidism in dialysis patients given calcium carbonate as a phosphate binder. J Nephrol 1991;2:75-81.
25. Teruel JL, Navarro JF, Marcen R, Aguilera A, Tato A, Ortuño J: Satisfactory control of secondary hyperparathyroidism with low-calcium dialysate in patients not receiving vitamin D. Miner Electrolyte Metab 1997;23:19-24.